Compare Esta Multi Usaha Tbk. (ESTA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Esta Multi Usaha Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Esta Multi Usaha Tbk. trades at Rp175 (market cap 424.44B, 135.9K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 26.3× Esta Multi Usaha Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 135.9K). Which is the better fit depends on your goals.
| ESTA | TSPC | |
|---|---|---|
Market Cap | 424.44B | 11.18T |
Volume | 135.9K | 613K |
Lot | 1.36K | 6.13K |
Turnover | 23.86M | 1.54B |
Average Price | 175.54 | 2,511.52 |
Value | 23.86M | 1.54B |
Indicative Equilibrium Price | 175 | 2,520 |
Indicative Equilibrium Volume | 3 | 17 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Esta Multi Usaha Tbk.
PT Esta Multi Usaha Tbk (the “Company”) was established under the name PT Esta Asri Propertindo, based on Notarial Deed No. 34 dated September 30, 2011 of Kun Hidayat, S.H., notary in Jakarta. The Company started its commercial operations in 2012. Until 2017, the Company only did real estate leasing business activities. In 2018, the Company started its hospitality business activities.Whereas in 2019, the Company commenced vehicle rental business activities without option rights.
Read more on ESTA →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
